28 Jul 2010 10:01
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||||||||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | ||||||||||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||||
|
An acquisition or disposal of voting rights | x | ||||||||||||
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| ||||||||||||
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| ||||||||||||
|
An event changing the breakdown of voting rights |
| ||||||||||||
|
Other (please specify): |
|
| |||||||||||
| 3. Full name of person(s) subject to the notification obligation:
| Smith & Williamson Holdings Limited | ||||||||||||
| 4. Full name of shareholder(s) (if different from 3.):
| See section 9 | ||||||||||||
| 5. Date of the transaction and date on which the threshold is crossed or reached:
| 22.07.10 | ||||||||||||
| 6. Date on which issuer notified:
| 27.07.10 | ||||||||||||
| 7. Threshold(s) that is/are crossed or reached:
| 5% | ||||||||||||
| 8. Notified details: | |||||||||||||
| A: Voting rights attached to shares
| |||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | |||||||||
| Direct | Direct | Indirect | Direct | Indirect | |||||||||
| Ordinary GB0034251727 | 10,029,600 | 10,029,600 |
|
| 11,029,600 |
| 5.28% | ||||||
|
| |||||||||||||
| B: Financial Instruments | |||||||||||||
| Resulting situation after the triggering transaction
| |||||||||||||
| Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights
| ||||||||
| N/A |
|
|
|
| Nominal | Delta
| |||||||
|
|
| ||||||||||||
| Total (A+B)
| |||||||||||||
| Number of voting rights | Percentage of voting rights | ||||||||||||
| 11,029,600 | 5.28% | ||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | |||||||||||||
| Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 3,759,600 shares
Bank of New York Nominees as custodian for Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 1,150,000 shares
BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 320,000 shares
BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 5,625,000
| |||||||||||||
| Proxy Voting:
| |||||||||||||
| 10. Name of the proxy holder:
| N/A | ||||||||||||
| 11. Number of voting rights proxy holder will cease to hold:
| N/A | ||||||||||||
| 12. Date on which proxy holder will cease to hold voting rights:
| N/A | ||||||||||||
| 13. Additional information:
|
| ||||||||||||
| 14. Contact name:
| Stephen Hamilton-Jones, Smith & Williamson Investment Management Limited | ||||||||||||
| 15. Contact telephone number:
| 020 7131 4734 | ||||||||||||